Tsuchimine S - Search Results

1

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder.

Aoki A, Ishiguro S, Watanabe T, Ueda M, Hayashi Y, Akiyama K, Kato K, Inoue Y, Tsuchimine S, Yasui-Furukori N, Shimoda K. Aoki A, et al. Among authors: tsuchimine s. Neuropsychiatr Dis Treat. 2014 Sep 18;10:1793-8. doi: 10.2147/NDT.S68670. eCollection 2014. Neuropsychiatr Dis Treat. 2014. PMID: 25258536 Free PMC article.

2

Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response.

Tomita T, Yasui-Furukori N, Sato Y, Nakagami T, Tsuchimine S, Kaneda A, Kaneko S. Tomita T, et al. Among authors: tsuchimine s. Neuropsychiatr Dis Treat. 2014 Apr 8;10:599-606. doi: 10.2147/NDT.S57189. eCollection 2014. Neuropsychiatr Dis Treat. 2014. PMID: 24748795 Free PMC article.

3

Factors Affecting Steady-state Plasma Concentrations of Enantiomeric Mirtazapine and its Desmethylated Metabolites in Japanese Psychiatric Patients.

Hayashi Y, Watanabe T, Aoki A, Ishiguro S, Ueda M, Akiyama K, Kato K, Inoue Y, Tsuchimine S, Yasui-Furukori N, Shimoda K. Hayashi Y, et al. Among authors: tsuchimine s. Pharmacopsychiatry. 2015 Nov;48(7):279-85. doi: 10.1055/s-0035-1565069. Epub 2015 Nov 23. Pharmacopsychiatry. 2015. PMID: 26595747

4

Association between plasma paroxetine concentration and changes in plasma brain‐derived neurotrophic factor levels in patients with major depressive disorder.

Yasui-Furukori N, Tsuchimine S, Nakagami T, Fujii A, Sato Y, Tomita T, Yoshizawa K, Inoue Y, Kaneko S. Yasui-Furukori N, et al. Among authors: tsuchimine s. Hum Psychopharmacol. 2011 Apr;26(3):194-200. doi: 10.1002/hup.1192. Hum Psychopharmacol. 2011. PMID: 21638327

5

The influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorder.

Tomita T, Yasui-Furukori N, Nakagami T, Tsuchimine S, Ishioka M, Kaneda A, Sugawara N, Kaneko S. Tomita T, et al. Among authors: tsuchimine s. PLoS One. 2014 May 23;9(5):e98099. doi: 10.1371/journal.pone.0098099. eCollection 2014. PLoS One. 2014. PMID: 24858363 Free PMC article.

6

Therapeutic reference range for plasma concentrations of paroxetine in patients with major depressive disorders.

Tomita T, Yasui-Furukori N, Nakagami T, Tsuchimine S, Ishioka M, Kaneda A, Nakamura K, Kaneko S. Tomita T, et al. Among authors: tsuchimine s. Ther Drug Monit. 2014 Aug;36(4):480-5. doi: 10.1097/FTD.0000000000000036. Ther Drug Monit. 2014. PMID: 25014076

7

A positive correlation between serum amyloid β levels and depressive symptoms among community-dwelling elderly individuals in Japan.

Tsuruga K, Sugawara N, Yasui-Furukori N, Takahashi I, Tsuchimine S, Kaneda A, Nakaji S, Nakamura K. Tsuruga K, et al. Among authors: tsuchimine s. Neuropsychiatr Dis Treat. 2014 Aug 30;10:1621-7. doi: 10.2147/NDT.S67205. eCollection 2014. Neuropsychiatr Dis Treat. 2014. PMID: 25210455 Free PMC article.

8

Effects of age on paroxetine efficacy in patients with major depressive disorder who do not exhibit an early response to treatment.

Tomita T, Sato Y, Nakagami T, Tsuchimine S, Kaneda A, Kaneko S, Nakamura K, Yasui-Furukori N. Tomita T, et al. Among authors: tsuchimine s. Clin Neuropharmacol. 2015 Jan-Feb;38(1):6-10. doi: 10.1097/WNF.0000000000000058. Clin Neuropharmacol. 2015. PMID: 25580920

9

Items of the Montgomery-Åsberg Depression Rating Scale Associated With Response to Paroxetine Treatment in Patients With Major Depressive Disorder.

Tomita T, Sato Y, Nakagami T, Tsuchimine S, Kaneda A, Kaneko S, Nakamura K, Yasui-Furukori N. Tomita T, et al. Among authors: tsuchimine s. Clin Neuropharmacol. 2016 May-Jun;39(3):135-9. doi: 10.1097/WNF.0000000000000146. Clin Neuropharmacol. 2016. PMID: 27171569

10

Influence of the cytochrome P450 2D6 *10/*10 genotype on the pharmacokinetics of paroxetine in Japanese patients with major depressive disorder: a population pharmacokinetic analysis.

Nishimura M, Ueda M, Saruwatari J, Nakashima H, Ogusu N, Aoki A, Tsuchimine S, Matsuda K, Iwashita K, Ono T, Oniki K, Shimoda K, Yasui-Furukori N. Nishimura M, et al. Among authors: tsuchimine s. Pharmacogenet Genomics. 2016 Sep;26(9):403-13. doi: 10.1097/FPC.0000000000000228. Pharmacogenet Genomics. 2016. PMID: 27187662

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page